Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
19 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 657099 |
30 | 3 | INFECTIOUS DISEASES//MICROBIOLOGY//JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 113720 |
633 | 2 | VANCOMYCIN//LINEZOLID//DAPTOMYCIN | 14131 |
12899 | 1 | TELAVANCIN//LIPOGLYCOPEPTIDE//CEFTAROLINE | 904 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | TELAVANCIN | authKW | 2356667 | 9% | 87% | 78 |
2 | LIPOGLYCOPEPTIDE | authKW | 1995722 | 7% | 94% | 61 |
3 | CEFTAROLINE | authKW | 1943256 | 8% | 77% | 72 |
4 | DALBAVANCIN | authKW | 1398329 | 6% | 70% | 57 |
5 | CEFTOBIPROLE | authKW | 1283491 | 5% | 78% | 47 |
6 | ORITAVANCIN | authKW | 855221 | 4% | 63% | 39 |
7 | CEFTAROLINE FOSAMIL | authKW | 614727 | 3% | 77% | 23 |
8 | ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS | authKW | 226592 | 1% | 50% | 13 |
9 | BAL9141 | authKW | 179290 | 1% | 86% | 6 |
10 | ABSSSI | authKW | 167324 | 1% | 40% | 12 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Microbiology | 20841 | 63% | 0% | 566 |
2 | Infectious Diseases | 14071 | 37% | 0% | 336 |
3 | Pharmacology & Pharmacy | 11992 | 66% | 0% | 596 |
4 | Immunology | 146 | 8% | 0% | 71 |
5 | Toxicology | 30 | 3% | 0% | 23 |
6 | Chemistry, Medicinal | 28 | 2% | 0% | 22 |
7 | Critical Care Medicine | 13 | 1% | 0% | 10 |
8 | Health Care Sciences & Services | 4 | 1% | 0% | 8 |
9 | Biotechnology & Applied Microbiology | 0 | 2% | 0% | 17 |
10 | Medicine, General & Internal | 0 | 2% | 0% | 19 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | ANTIINFECT CHEM | 108941 | 1% | 63% | 5 |
2 | MS MICROBIOL 673 | 69724 | 0% | 100% | 2 |
3 | BEAVER KREEK 345 | 48491 | 1% | 17% | 8 |
4 | UNITE PHARMACOL CELLULAIRE MOL | 42522 | 1% | 10% | 12 |
5 | ANTIINFECT DEV | 40307 | 2% | 6% | 18 |
6 | ANTIINFECT | 38126 | 2% | 6% | 18 |
7 | ABDOMINAL TRAUMATOL ORTHOPED SURG | 34862 | 0% | 100% | 1 |
8 | ADULT ANTIMICROBIAL STEWARDSHIP PHARM | 34862 | 0% | 100% | 1 |
9 | AFFILIATED HOSP P DIS 1 | 34862 | 0% | 100% | 1 |
10 | ANTIINFECT INVEST SECT | 34862 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 82952 | 27% | 1% | 240 |
2 | DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 26988 | 7% | 1% | 65 |
3 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 23466 | 10% | 1% | 93 |
4 | INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 20988 | 5% | 1% | 49 |
5 | EXPERT REVIEW OF ANTI-INFECTIVE THERAPY | 5683 | 1% | 1% | 13 |
6 | CLINICAL INFECTIOUS DISEASES | 4166 | 4% | 0% | 40 |
7 | FUTURE MICROBIOLOGY | 3263 | 1% | 1% | 10 |
8 | JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE | 3148 | 1% | 2% | 5 |
9 | THERAPEUTICS AND CLINICAL RISK MANAGEMENT | 2549 | 1% | 1% | 8 |
10 | JOURNAL OF CHEMOTHERAPY | 1975 | 1% | 0% | 12 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TELAVANCIN | 2356667 | 9% | 87% | 78 | Search TELAVANCIN | Search TELAVANCIN |
2 | LIPOGLYCOPEPTIDE | 1995722 | 7% | 94% | 61 | Search LIPOGLYCOPEPTIDE | Search LIPOGLYCOPEPTIDE |
3 | CEFTAROLINE | 1943256 | 8% | 77% | 72 | Search CEFTAROLINE | Search CEFTAROLINE |
4 | DALBAVANCIN | 1398329 | 6% | 70% | 57 | Search DALBAVANCIN | Search DALBAVANCIN |
5 | CEFTOBIPROLE | 1283491 | 5% | 78% | 47 | Search CEFTOBIPROLE | Search CEFTOBIPROLE |
6 | ORITAVANCIN | 855221 | 4% | 63% | 39 | Search ORITAVANCIN | Search ORITAVANCIN |
7 | CEFTAROLINE FOSAMIL | 614727 | 3% | 77% | 23 | Search CEFTAROLINE+FOSAMIL | Search CEFTAROLINE+FOSAMIL |
8 | ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS | 226592 | 1% | 50% | 13 | Search ACUTE+BACTERIAL+SKIN+AND+SKIN+STRUCTURE+INFECTIONS | Search ACUTE+BACTERIAL+SKIN+AND+SKIN+STRUCTURE+INFECTIONS |
9 | BAL9141 | 179290 | 1% | 86% | 6 | Search BAL9141 | Search BAL9141 |
10 | ABSSSI | 167324 | 1% | 40% | 12 | Search ABSSSI | Search ABSSSI |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |